Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
J. Strosberg, P. Kunz, A. Hendifar, James C. Yao, D. Bushnell, M. Kulke, R. Baum, M. Caplin, P. Ruszniewski, E. Delpassand, T. Hobday, C. Verslype, A. Benson, R. Srirajaskanthan, M. Pavel, J. Mora, J. Berlin, E. Grande, N. Reed, E. Seregni, G. Paganelli, S. Severi, M. Morse, D. Metz, C. Ansquer, F. Courbon, A. Al-Nahhas, E. Baudin, F. Giammarile, D. Taïeb, E. Mittra, E. Wolin, T. O'Dorisio, R. Lebtahi, C. Deroose, C. Grana, L. Bodei, K. Öberg, B. Polack, B. He, M. Mariani, G. Gericke, P. Santoro, J. Erion, L. Ravasi, E. Krenning
European Journal of Nuclear Medicine and Molecular Imaging